1997
DOI: 10.1007/s002850050076
|View full text |Cite
|
Sign up to set email alerts
|

Optimal control of the chemotherapy of HIV

Abstract: Abstract. Using an existing ordinary differential equation model which describes the interaction of the immune system with the human immunodeficiency virus (HIV), we introduce chemotherapy in an early treatment setting through a dynamic treatment and then solve for an optimal chemotherapy strategy. The control represents the percentage of effect the chemotherapy has on the viral production. Using an objective function based on a combination of maximizing benefit based on T cell counts and minimizing the system… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
330
0
2

Year Published

2002
2002
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 427 publications
(334 citation statements)
references
References 22 publications
2
330
0
2
Order By: Relevance
“…Standard techniques in optimal control, Hamiltonian and Pontryagin's Maximum Principles, are applied to derive the optimal solution and the problem is solved numerically for several scenarios. In Kirschner et al [15] the objective is to minimize the systematic cost of chemotherapy in early HIV treatment. The interaction of the immune system with HIV is described by an ODE model.…”
Section: Introductionmentioning
confidence: 99%
“…Standard techniques in optimal control, Hamiltonian and Pontryagin's Maximum Principles, are applied to derive the optimal solution and the problem is solved numerically for several scenarios. In Kirschner et al [15] the objective is to minimize the systematic cost of chemotherapy in early HIV treatment. The interaction of the immune system with HIV is described by an ODE model.…”
Section: Introductionmentioning
confidence: 99%
“…For example, Kirschner, Lenhart, and Serbin (Ref. 8) consider an optimal control problem for chemotherapy of HIV which accounts for latently and actively infected CD4 + T-cells; Fister and Panetta (Ref. 9) analyze a mathematical model which takes into account bone marrow destruction.…”
Section: Introductionmentioning
confidence: 99%
“…The combined short and long period treatment schemes aims at providing a standard and effective treatment in the attack phase and, after the improvement of the patient's condition, a maintenance treatment based on optimized doses that has less side-effects yet keeps the health condition in a clinically satisfactory region. In the previous results by the authors, the original non-linear model was used to compute the optimal strategy for the whole control horizon (see, for instance, Caetano and Yoneyama 1999b, Felippe de Souza et al 2000, Kirschner and Webb 1996and Kirschner et al 1997). However, it was very difficult to extend them for computing long term treatment schemes.…”
Section: Discussionmentioning
confidence: 99%